Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Heymann

Showing results (171-180 of 243) with videos related to

Pageof 25
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2011
Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma modelsJulie Rousseau, Virginie Escriou, François Lamoureux, et al.
Plastic and Reconstructive Surgery|February 25, 2016
Opposite Effects of Soluble Factors Secreted by Adipose Tissue on Proliferating and Quiescent Osteosarcoma CellsPierre Avril, Franck Duteille, Perrine Ridel, et al.
Journal of Bone Oncology|February 25, 2016
Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKLGaëlle Picarda, Etienne Matous, Jérôme Amiaud, et al.
International Journal of Cancer|June 26, 2014
BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcomaBérengère Gobin, Marc Baud' Huin, François Lamoureux, et al.
International Journal of Biological Macromolecules|March 21, 2025
A new promising anticancer agent: A glycosaminoglycan-mimetic derived from the marine bacterial infernan exopolysaccharideDominique Heymann, Javier Muñoz-Garcia, Antoine Babuty, et al.
Atherosclerosis|March 4, 2011
Carotid and femoral atherosclerotic plaques show different morphologyFanny Herisson, Marie-Françoise Heymann, Maud Chétiveaux, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 18, 2013
Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissueFrédéric Deschaseaux, Julien Gaillard, Alain Langonné, et al.
American Journal of Cancer Research|December 9, 2017
Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modelingVincent Crenn, Kevin Biteau, Jérôme Amiaud, et al.
Scientific Reports|October 10, 2019
Hemophilia A and B mice, but not VWF<sup>-/-</sup>mice, display bone defects in congenital development and remodeling after injurySarah Taves, Junjiang Sun, Eric W Livingston, et al.
Plos One|June 15, 2010
Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrencePierre Perrot, Julie Rousseau, Anne-Laure Bouffaut, et al.
Pageof 25

Showing results (171-180 of 243) with videos related to

Sort By:
Pageof 25
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2011
Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma modelsJulie Rousseau, Virginie Escriou, François Lamoureux, et al.
Plastic and Reconstructive Surgery|February 25, 2016
Opposite Effects of Soluble Factors Secreted by Adipose Tissue on Proliferating and Quiescent Osteosarcoma CellsPierre Avril, Franck Duteille, Perrine Ridel, et al.
Journal of Bone Oncology|February 25, 2016
Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKLGaëlle Picarda, Etienne Matous, Jérôme Amiaud, et al.
International Journal of Cancer|June 26, 2014
BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcomaBérengère Gobin, Marc Baud' Huin, François Lamoureux, et al.
International Journal of Biological Macromolecules|March 21, 2025
A new promising anticancer agent: A glycosaminoglycan-mimetic derived from the marine bacterial infernan exopolysaccharideDominique Heymann, Javier Muñoz-Garcia, Antoine Babuty, et al.
Atherosclerosis|March 4, 2011
Carotid and femoral atherosclerotic plaques show different morphologyFanny Herisson, Marie-Françoise Heymann, Maud Chétiveaux, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 18, 2013
Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissueFrédéric Deschaseaux, Julien Gaillard, Alain Langonné, et al.
American Journal of Cancer Research|December 9, 2017
Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modelingVincent Crenn, Kevin Biteau, Jérôme Amiaud, et al.
Scientific Reports|October 10, 2019
Hemophilia A and B mice, but not VWF<sup>-/-</sup>mice, display bone defects in congenital development and remodeling after injurySarah Taves, Junjiang Sun, Eric W Livingston, et al.
Plos One|June 15, 2010
Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrencePierre Perrot, Julie Rousseau, Anne-Laure Bouffaut, et al.
Pageof 25